Recommendations on the use of recombinant activated factor VII as an adjunctive treatment for massive bleeding – a European perspective

[1]  S. Mayer,et al.  Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage , 2007, Stroke.

[2]  Rolf Rossaint,et al.  Pharmacokinetics of recombinant activated factor VII in trauma patients with severe bleeding , 2006, Critical care.

[3]  M. Braun,et al.  Thromboembolic adverse events after use of recombinant human coagulation factor VIIa. , 2006, JAMA.

[4]  D. O'shaughnessy,et al.  Activated recombinant factor VII after cardiopulmonary bypass reduces allogeneic transfusion in complex non-coronary cardiac surgery: randomized double-blind placebo-controlled pilot study. , 2005, British journal of anaesthesia.

[5]  R. MacLaren,et al.  Consensus recommendations for the off-label use of recombinant human factor VIIa (NovoSeven®) therapy , 2005 .

[6]  M. Raux,et al.  Recombinant activated factor vii to control massive post operative bleeding after septic aortobifemoral grafting. , 2005, European journal of anaesthesiology.

[7]  K. Wernecke,et al.  Recombinant activated factor VII for refractory bleeding after cardiac surgery—A retrospective analysis of safety and efficacy , 2005, Critical Care Medicine.

[8]  A. Morey,et al.  Factor VIIa for correction of traumatic coagulopathy. , 2005, The Journal of urology.

[9]  P. Coriat,et al.  Early hypocalcemia in severe trauma* , 2005, Critical care medicine.

[10]  J. García-Valdecasas,et al.  Efficacy and safety of repeated perioperative doses of recombinant factor VIIa in liver transplantation , 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[11]  A. Jeppsson,et al.  Recombinant activated factor VII in the management of life-threatening bleeding in cardiac surgery. , 2005, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[12]  G. Klintmalm,et al.  Safety and efficacy of a single bolus administration of recombinant factor VIIa in liver transplantation due to chronic liver disease , 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[13]  R Rossaint,et al.  Coagulopathy and blood component transfusion in trauma. , 2005, British journal of anaesthesia.

[14]  R. Suojaranta-Ylinen,et al.  Recombinant factor VIIa in the treatment of postoperative hemorrhage after cardiac surgery. , 2005, The Annals of thoracic surgery.

[15]  Michael D Pasquale,et al.  "Low-dose" recombinant activated factor VII results in less blood and blood product use in traumatic hemorrhage. , 2005, The Journal of trauma.

[16]  R. Rossaint,et al.  Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials. , 2005, The Journal of trauma.

[17]  A. Geha,et al.  Use of recombinant activated factor VII for bleeding following operations requiring cardiopulmonary bypass. , 2005, Chest.

[18]  R. Grounds,et al.  Use of activated recombinant coagulation factor VII in patients undergoing reconstruction surgery for traumatic fracture of pelvis or pelvis and acetabulum: a double-blind, randomized, placebo-controlled trial. , 2005, British journal of anaesthesia.

[19]  H. Büller,et al.  Efficacy and safety of recombinant factor VIIa for treatment of severe bleeding: A systematic review , 2005, Critical care medicine.

[20]  M. Michaelson,et al.  Guidelines for the use of recombinant activated factor VII (rFVIIa) in uncontrolled bleeding: a report by the Israeli Multidisciplinary rFVIIa Task Force , 2005, Journal of thrombosis and haemostasis : JTH.

[21]  W. Bechstein,et al.  Recombinant Coagulation Factor VIIa in Major Liver Resection: A Randomized, Placebo-controlled, Double-blind Clinical Trial , 2005, Anesthesiology.

[22]  S. McCluskey,et al.  Recombinant factor VIIa for intractable blood loss after cardiac surgery: a propensity score–matched case‐control analysis , 2005, Transfusion.

[23]  J. Borrás-Blasco,et al.  Recombinant Factor VIIa is an Effective Therapy for Abdominal Surgery and Severe Thrombocytopenia: A Case Report , 2005, International journal of hematology.

[24]  E. Riley,et al.  Recombinant factor VIIa for life-threatening post-partum haemorrhage. , 2005, British journal of anaesthesia.

[25]  A. Aggarwal,et al.  Recombinant activated factor VII (rFVIIa) as salvage treatment for intractable hemorrhage , 2004, Thrombosis journal.

[26]  D. Thabut,et al.  Recombinant factor VIIa for upper gastrointestinal bleeding in patients with cirrhosis: a randomized, double-blind trial. , 2004, Gastroenterology.

[27]  D. Gabriel,et al.  Recombinant human factor VIIa (rFVIIa) can activate factor FIX on activated platelets , 2004, Journal of thrombosis and haemostasis : JTH.

[28]  C. Eby,et al.  Transfusion medicine service policies for recombinant factor VIIa administration , 2004, Transfusion.

[29]  Mitchell M. Levy,et al.  Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock , 2004, Critical care medicine.

[30]  P. Fontana,et al.  Prolonged treatment of massive postpartum haemorrhage with recombinant factor VIIa: case report and review of the literature , 2004, BJOG : an international journal of obstetrics and gynaecology.

[31]  G. Ramsay,et al.  Successful treatment of severe bleeding with recombinant factor VIIa after kidney transplantation , 2004, Intensive Care Medicine.

[32]  D. Hoyt,et al.  The epidemiology of serious and fatal injury in San Diego County over an 11-year period. , 2004, The Journal of trauma.

[33]  T. Deloughery,et al.  Coagulation defects in trauma patients: etiology, recognition, and therapy. , 2004, Critical care clinics.

[34]  D. Hoyt.  A clinical review of bleeding dilemmas in trauma. , 2004, Seminars in hematology.

[35]  Alisa S Wolberg,et al.  The effect of temperature and pH on the activity of factor VIIa: implications for the efficacy of high-dose factor VIIa in hypothermic and acidotic patients. , 2003, The Journal of trauma.

[36]  Maureane Hoffman,et al.  A cell-based model of coagulation and the role of factor VIIa. , 2003, Blood reviews.

[37]  G. D’Amico,et al.  Upper digestive bleeding in cirrhosis. Post‐therapeutic outcome and prognostic indicators , 2003, Hepatology.

[38]  H. V. van Geijn,et al.  Successful Treatment of Life‐Threatening Postpartum Hemorrhage With Recombinant Activated Factor VII , 2003, Obstetrics and gynecology.

[39]  J. Kotarski,et al.  Successful Treatment With Recombinant Factor VIIa for Intractable Bleeding at Pelvic Surgery , 2003, Obstetrics and gynecology.

[40]  Thomas M Scalea,et al.  Blood transfusion, independent of shock severity, is associated with worse outcome in trauma. , 2003, The Journal of trauma.

[41]  H. Ng,et al.  Successful control of postsurgical bleeding by recombinant factor VIIa in a renal failure patient given low molecular weight heparin and aspirin , 2003, Annals of Hematology.

[42]  J. van der Meer,et al.  Recombinant factor VIIa in orthotopic liver transplantation: influence on parameters of coagulation and fibrinolysis , 2003, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[43]  K. Kurth,et al.  Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: a double-blind placebo-controlled randomised trial , 2003, The Lancet.

[44]  D. Monroe,et al.  The action of high-dose factor VIIa (FVIIa) in a cell-based model of hemostasis. , 2001, Disease-a-month : DM.

[45]  R. Blumenthal,et al.  Treatment of obstetric hemorrhage with recombinant activated factor VII (rFVIIa) , 2003, Archives of Gynecology and Obstetrics.

[46]  E. Erhardtsen.  Ongoing NovoSeven® trials , 2002, Intensive Care Medicine.

[47]  U. Martinowitz,et al.  Updates in the management of severe coagulopathy in trauma patients , 2002, Intensive Care Medicine.

[48]  J. Vincent,et al.  Anemia and blood transfusion in critically ill patients. , 2002, JAMA.

[49]  Jeffrey S. Young,et al.  Blood Transfusions Correlate with Infections in Trauma Patients in a Dose-Dependent Manner , 2002, The American surgeon.

[50]  V. Seifert,et al.  Application of recombinant activated factor VII during surgery for a giant skull base hemangiopericytoma to achieve safe hemostasis. Case report. , 2002, Journal of neurosurgery.

[51]  E. Stuth,et al.  Treatment of Bleeding in Severe Necrotizing Pancreatitis with Recombinant Factor VIIa , 2002 .

[52]  A. Spotnitz,et al.  Re-exploration for hemorrhage following open heart surgery differentiation on the causes of bleeding and the impact on patient outcomes. , 2001, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia.

[53]  E. Segal,et al.  Recombinant activated factor VII for adjunctive hemorrhage control in trauma. , 2001, The Journal of trauma.

[54]  M. Sanz,et al.  Successful treatment of severe intra‐abdominal bleeding associated with disseminated intravascular coagulation using recombinant activated factor VII , 2001, British journal of haematology.

[55]  R. Porte,et al.  REDUCED TRANSFUSION REQUIREMENTS BY RECOMBINANT FACTOR VIIa IN ORTHOTOPIC LIVER TRANSPLANTATION: A Pilot Study , 2001, Transplantation.

[56]  C. Gaillard,et al.  Treatment of a severely bleeding patient without preexisting coagulopathy with activated recombinant factor VII. , 2000, The American journal of medicine.

[57]  C. Baird,et al.  The pilot study. , 2000, Orthopedic nursing.

[58]  Ravi,et al.  SUCCESSFUL USE OF RECOMBINANT FVIIa (NOVOSEVEN®) IN THE MANAGEMENT OF INTRACTABLE POST‐SURGICAL INTRA‐ABDOMINAL HAEMORRHAGE , 1999, British journal of haematology.

[59]  V. Fuster,et al.  Acute Coronary Syndromes: Pathophysiology and Preventive Priorities , 1999, Thrombosis and Haemostasis.

[60]  M. Schepens,et al.  Recombinant Activated Factor VII for False Aneurysms in Patients with Normal Haemostatic Mechanisms , 1999, Thrombosis and Haemostasis.

[61]  C Kaufmann,et al.  Hypothermic coagulopathy in trauma: effect of varying levels of hypothermia on enzyme speed, platelet function, and fibrinolytic activity. , 1998, The Journal of trauma.

[62]  K. Reddy,et al.  Recombinant factor VIIa corrects prothrombin time in cirrhotic patients: a preliminary study. , 1997, Gastroenterology.

[63]  A. Sauaia,et al.  Blood Transfusion: An Independent Risk Factor for Postinjury Multiple Organ Failure , 1997 .

[64]  E. Bramucci,et al.  Tissue-factor antigen and activity in human coronary atherosclerotic plaques , 1997, The Lancet.

[65]  V. Fuster,et al.  Tissue factor modulates the thrombogenicity of human atherosclerotic plaques. , 1997, Circulation.

[66]  Andrew D. Rosenberg,et al.  Practice Guidelines for Blood Component Therapy: A Report by the American Society of Anesthesiologists Task Force on Blood Component Therapy , 1996, Anesthesiology.

[67]  A. Sauaia,et al.  Epidemiology of trauma deaths: a reassessment. , 1993, The Journal of trauma.

[68]  M M Knudson,et al.  Death in the operating room: an analysis of a multi-center experience. , 1995, The Journal of trauma.

[69]  D. Heimbach,et al.  Clotting factor levels and the risk of diffuse microvascular bleeding in the massively transfused patient , 1987, British journal of haematology.

[70]  Ronald V. Maier,et al.  Incidence and effect of hypothermia in seriously injured patients. , 1986, The Journal of trauma.

[71]  Martin Hynes,et al.  Human Blood Coagulation and its Disorders , 1958 .

[72]  R. Biggs,et al.  Human Blood Coagulation and its Disorders , 1958 .